Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Aussie State Approves Unindicated Use Of Antiviral For Hendra Virus

This article was originally published in PharmAsia News

Executive Summary

Australian authorities have begun providing an antiviral for an unindicated use for people exposed to the Hendra virus that is spreading among horses in the country. Four people exposed to the virus were offered Ribavirin developed by Three Rivers Pharmaceuticals and commonly used for treating hepatitis C. Queensland health authorities approved use of the drug in an effort to prevent further infection of humans who may have been in contact with infected horses. One horse-handler died the day after she handled a Hendra-infected horse. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072469

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel